Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-01 @ 1:36 AM
Study NCT ID:
NCT06977893
Status:
RECRUITING
Last Update Posted:
2025-05-18
First Post:
2025-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-23
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-12
First Submit QC Date:
None
Study First Post Date:
2025-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-12
Last Update Post Date:
2025-05-18
Last Update Post Date Type:
ACTUAL